Global Blood Therapeutics, Inc. (GBT)
(Delayed Data from NSDQ)
$55.18 USD
+1.34 (2.49%)
Updated May 3, 2019 04:00 PM ET
After-Market: $55.12 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[GBT]
Reports for Purchase
Showing records 181 - 200 ( 340 total )
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
3Q19 Voxelotor Has a Big Presence at ASH; 1Q20 PDUFA the Next Milestone
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Q3 Financials; New Voxelotor Data at EHA Reinforces Our Bullish View
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Post-hoc Analysis of Voxelotor/SCD Phase 3 Shows Improvement in Leg Ulcers
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Analyst Day Highlights Voxelotor?s Impressive Clinical Profile; KOLs Excited
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Pending PDUFA Action, Voxelotor Appears to Be Launch Ready
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Multiple SCD Presentations at SCDAA; Analyst Day on Oct 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Model Updates Into the Anticipated 1Q20 Voxelotor Launch
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Another Bear Thesis Takes the Back Seat
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
NDA Acceptance for Voxelotor; PDUFA Date February 26, 2020; PT to $120
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
2H19 Value Drivers Within Our Coverage Universe
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D